Nehal E. Elsadek
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 7
- Extracellular vesicles in disease 3
- Protein purification and stability 2
-
- Immunotherapy and Immune Responses 5
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Tatsuhiro Ishida (15 shared papers)Sherif E. Emam (14 shared papers)Taro Shimizu (13 shared papers)Yu Ishima (12 shared papers)Hidenori Ando (13 shared papers)Hatem A. Sarhan (5 shared papers)Amr S. Abu Lila (8 shared papers)Amal K. Hussein (2 shared papers)
- Journals
- Journal of Controlled Release (4 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Biological and Pharmaceutical Bulletin (2 papers)International Journal of Pharmaceutics (2 papers)Molecular Pharmaceutics (2 papers)
- Partner nations
- JapanEgyptSaudi Arabia
In The Last Decade
Nehal E. Elsadek
17 papers receiving 697 citations
Nehal E. Elsadek's Hit Papers
Peers
Comparison fields: 5 of 104
- Biomaterials 218
- Pharmaceutical Science 61
- Cancer Research 67
- Molecular Biology 318
- Immunology 92
Countries citing papers authored by Nehal E. Elsadek
This map shows the geographic impact of Nehal E. Elsadek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nehal E. Elsadek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nehal E. Elsadek more than expected).
Fields of papers citing papers by Nehal E. Elsadek
This network shows the impact of papers produced by Nehal E. Elsadek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nehal E. Elsadek. The network helps show where Nehal E. Elsadek may publish in the future.
Co-authors
The 22 scholars most cited alongside Nehal E. Elsadek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products Hit paper breakdown → | 2022 | 328 |
| 2 | 2019 | 67 | |
| 3 | 2021 | 64 | |
| 4 | 2020 | 46 | |
| 5 | 2020 | 35 | |
| 6 | 2022 | 35 | |
| 7 | 2023 | 29 | |
| 8 | 2020 | 22 | |
| 9 | 2019 | 20 | |
| 10 | 2022 | 14 | |
| 11 | 2021 | 11 | |
| 12 | 2020 | 11 | |
| 13 | 2023 | 9 | |
| 14 | 2021 | 8 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 3 | |
| 17 | 2022 | 1 | |
| 18 | 2025 | 0 |
About Nehal E. Elsadek
Nehal E. Elsadek is a scholar working on Molecular Biology, Immunology, Biomaterials, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 18 papers that have together received 708 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Extracellular vesicles in disease (3 papers), Protein purification and stability (2 papers), Drug-Induced Adverse Reactions (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Biomaterials (218 citations), Pharmaceutical Science (61 citations), Cancer Research (67 citations), Molecular Biology (318 citations) and Immunology (92 citations). Nehal E. Elsadek has collaborated with scholars based in Japan, Egypt and Saudi Arabia. Frequent co-authors include Tatsuhiro Ishida, Sherif E. Emam, Taro Shimizu, Yu Ishima, Hidenori Ando, Hatem A. Sarhan, Amr S. Abu Lila, Amal K. Hussein, Omar H. El-Garhy and Eslam Ramadan. Their work appears in journals such as Journal of Controlled Release, European Journal of Pharmaceutics and Biopharmaceutics, Biological and Pharmaceutical Bulletin, International Journal of Pharmaceutics and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.